Kleiner Perkins Leads $6M Seed Round in Health Universe

San Francisco startup’s HIPAA-compliant AI has processed 170M+ clinical docs and cut trial setup from months to days, backed by Kleiner Perkins.

Health Universe, a San Francisco-based enterprise AI platform, raised $6 million in seed funding led by Kleiner Perkins, bringing total capital raised to $9.5 million. The round follows a 2023 pre-seed backed by Susa Ventures, Twelve Below, and Oncology Ventures. New capital will fund expansion across academic medical centers, health systems, and life sciences organizations. 

The company offers a workspace for deploying AI agents against patient records retrieved via TEFCA and FHIR protocols. Its platform, comprising three core modules called Navigator, Explorer, and Observer, is ONC B.11 certified, SOC 2 Type II compliant, and fully HIPAA-aligned. Health Universe says those certifications typically require competitors 12 to 18 months and significant capital to obtain. 

The move comes as clinician burnout and administrative overload push healthcare organizations to adopt AI tools capable of operating under regulatory scrutiny. Most AI systems in clinical settings remain difficult to audit, limiting adoption in high-stakes environments. Health Universe addresses that gap with source-linked outputs and an agent monitoring layer that tracks costs, flags hallucinations, and identifies high-risk scenarios. 

Healthcare doesn’t need another chatbot. It needs AI systems that are traceable, compliant, and built for real clinical workflows.
Dan Caron, founder and CEO, Health Universe

Results at Duke Clinical Research Institute illustrate the platform’s scope. Health Universe’s Project Loom initiative reduced clinical trial setup from 6 to 9 months down to approximately 7.5 days, a 30 to 40 times acceleration, while delivering 93% time savings across key workflow tasks. The company built its clinical trials agent in conjunction with DCRI; it converts brief study synopses into 75-page trial protocols and automates ClinicalTrials.gov submissions. 

On the oncology side, the platform consolidates fragmented medical records into structured summaries that cover diagnosis, staging, biomarkers, and treatment history. It is deployed at several oncology practices, including New York Cancer and Blood Specialists. Since launching Navigator, the platform has processed over 170 million clinical documents. 

Annie Case of Kleiner Perkins cited compliance infrastructure as the deciding factor. “Health Universe has built the rare combination of technical sophistication and regulatory readiness required for academic medicine,” Case said in the press release. Kleiner Perkins has previously backed digital health companies, including One Medical and Devoted Health. 

Health Universe is also developing an Agent-to-Agent Marketplace, a network allowing AI agents across different organizations to exchange documents and coordinate work within governed parameters. It’s unclear when that product will reach general availability. The company said new hires will focus on engineering and data science as it deepens integrations with oncology and clinical research teams. 

Disclaimer: This article is based on publicly available reporting. Nervnow has not independently verified the claims.

MORE ON STARTUPS & FUNDING:
Oasis Security Raises $120 Million to Govern AI Agent Access
Surf AI Raises $57M Series A to Scale AI Security Platform 
Agnes AI Raises Tens of Millions in Funding
One-Year-Old Wonderful Raises $150M in New Funding
DiligenceSquared Raises $5M to Let AI Do What McKinsey Charges $1M For